We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nicotine Pouches Hit 55.7% of Oral Tobacco: Where Does Altria Stand?
Read MoreHide Full Article
Key Takeaways
Nicotine pouches reached 55.7% of the U.S. oral tobacco market, challenging Altria to keep pace.
Promotions pushed pouch prices sharply lower even as Altria increased on!'s retail price.
Altria launched on! PLUS in select states, aiming for better comfort, delivery and flavor.
Altria Group, Inc. ((MO - Free Report) ) is facing a pivotal moment as nicotine pouches surge to 55.7% of the U.S. oral tobacco market in the third quarter of 2025, an 11.1-point year-over-year expansion that is reshaping category dynamics. The company’s challenge is clear: keeping pace with the fast-growing oral segment. While on! held an 8.7% share of the total U.S. oral tobacco category, its position within the nicotine pouch segment slipped to 15.6%, down 4.1 points amid highly elevated competitor promotional activity.
During the third quarter, competitor promotions drove the nicotine pouch category’s average retail prices down 7% nationally, with declines of more than 70% in a major retail chain. Altria noted that on!’s retail price increased approximately 1.5% over the same period, reflecting a different pricing trend than the broader category. Despite these conditions, the company highlighted that retail takeaway for on! remained “steady,” indicating consistent consumer demand during a highly promotional environment.
To strengthen its position in the evolving segment, Altria is rolling out on! PLUS, its next-generation pouch designed to enhance comfort, nicotine delivery and flavor satisfaction. The product launched in Florida, Texas and North Carolina, and early research showed higher purchase intent versus several competing brands.
As nicotine pouches continue to expand within the oral tobacco market, on!’s performance and the rollout of on! PLUS will determine how Altria positions itself within this rapidly growing category. The company’s efforts in pricing, product innovation and distribution will shape its trajectory as the segment evolves.
Where PM and TPB Stand Next to Altria
Philip Morris International Inc. ((PM - Free Report) ) showed strong momentum in its modern oral portfolio in the third quarter of 2025, with global pouch shipments rising 16.9% and U.S. ZYN offtake growing 39%, according to Nielsen estimates. Including select short-term relaunch promotions following earlier supply constraints, ZYN was fully available to the trade and supported by a wide range of commercial activities, Philip Morris noted. Philip Morris also emphasized continued investments in capacity and commercialization to meet rising demand in the nicotine pouch segment.
Turning Point Brands, Inc. ((TPB - Free Report) ) delivered exceptionally strong modern oral growth in the third quarter of 2025, with segment net sales surging 627.6% year over year to $36.7 million. Now it represents nearly 30.8% of the company's revenues. Turning Point Brands highlighted sequential modern oral growth of 22% and raised its full-year modern oral sales outlook to $125-$130 million. Management also noted progress toward qualifying its first U.S. white-pouch production lines in 2026, underscoring Turning Point Brands’ growing presence in the nicotine pouch category.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have lost 9.8% in the past month compared with the industry’s decline of 1.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.47X, down from the industry’s average of 14.12X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.5%, respectively.
Image: Bigstock
Nicotine Pouches Hit 55.7% of Oral Tobacco: Where Does Altria Stand?
Key Takeaways
Altria Group, Inc. ((MO - Free Report) ) is facing a pivotal moment as nicotine pouches surge to 55.7% of the U.S. oral tobacco market in the third quarter of 2025, an 11.1-point year-over-year expansion that is reshaping category dynamics. The company’s challenge is clear: keeping pace with the fast-growing oral segment. While on! held an 8.7% share of the total U.S. oral tobacco category, its position within the nicotine pouch segment slipped to 15.6%, down 4.1 points amid highly elevated competitor promotional activity.
During the third quarter, competitor promotions drove the nicotine pouch category’s average retail prices down 7% nationally, with declines of more than 70% in a major retail chain. Altria noted that on!’s retail price increased approximately 1.5% over the same period, reflecting a different pricing trend than the broader category. Despite these conditions, the company highlighted that retail takeaway for on! remained “steady,” indicating consistent consumer demand during a highly promotional environment.
To strengthen its position in the evolving segment, Altria is rolling out on! PLUS, its next-generation pouch designed to enhance comfort, nicotine delivery and flavor satisfaction. The product launched in Florida, Texas and North Carolina, and early research showed higher purchase intent versus several competing brands.
As nicotine pouches continue to expand within the oral tobacco market, on!’s performance and the rollout of on! PLUS will determine how Altria positions itself within this rapidly growing category. The company’s efforts in pricing, product innovation and distribution will shape its trajectory as the segment evolves.
Where PM and TPB Stand Next to Altria
Philip Morris International Inc. ((PM - Free Report) ) showed strong momentum in its modern oral portfolio in the third quarter of 2025, with global pouch shipments rising 16.9% and U.S. ZYN offtake growing 39%, according to Nielsen estimates. Including select short-term relaunch promotions following earlier supply constraints, ZYN was fully available to the trade and supported by a wide range of commercial activities, Philip Morris noted. Philip Morris also emphasized continued investments in capacity and commercialization to meet rising demand in the nicotine pouch segment.
Turning Point Brands, Inc. ((TPB - Free Report) ) delivered exceptionally strong modern oral growth in the third quarter of 2025, with segment net sales surging 627.6% year over year to $36.7 million. Now it represents nearly 30.8% of the company's revenues. Turning Point Brands highlighted sequential modern oral growth of 22% and raised its full-year modern oral sales outlook to $125-$130 million. Management also noted progress toward qualifying its first U.S. white-pouch production lines in 2026, underscoring Turning Point Brands’ growing presence in the nicotine pouch category.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have lost 9.8% in the past month compared with the industry’s decline of 1.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.47X, down from the industry’s average of 14.12X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.5%, respectively.
Image Source: Zacks Investment Research
Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.